<div class="table-responsive">
    <table class="table table-striped table-hover">
        <thead>
            <tr>
                
                <th scope="col">
                    <a href="?cresstrial=10497&amp;modal=1&amp;valnames=arms&amp;order=created_at">Created at</a>
                </th>
                <th scope="col">Source</th>
                
                <th scope="col">Raw Value</th>
                <th scope="col">Validated value</th>
            </tr>
        </thead>
        <tbody>
            
            <tr class="histvalue-row" histvalueid="418500" class="table-">
                
                <td>July 7, 2022, 1:30 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine;- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 285, &quot;treatment_name&quot;: &quot;Cigb 2020&quot;, &quot;treatment_type&quot;: &quot;Non covid vaccine&quot;, &quot;pharmacological_treatment&quot;: &quot;Non covid vaccine&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="415204" class="table-">
                
                <td>June 23, 2022, 2 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 285, &quot;treatment_name&quot;: &quot;Cigb 2020&quot;, &quot;treatment_type&quot;: &quot;Non covid vaccine&quot;, &quot;pharmacological_treatment&quot;: &quot;Non covid vaccine&quot;}, {&quot;arm_notes&quot;: &quot;no third arm. to delete&quot;, &quot;treatment_id&quot;: 285, &quot;treatment_name&quot;: &quot;Cigb 2020&quot;, &quot;treatment_type&quot;: &quot;Non covid vaccine&quot;, &quot;pharmacological_treatment&quot;: &quot;Non covid vaccine&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="414294" class="table-">
                
                <td>June 17, 2022, 12:30 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;CIGB 2020 vaccine;Administration; Intranasal ;Administration; Sublingual;Immunotherapy; Active;- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 285, &quot;treatment_name&quot;: &quot;Cigb 2020&quot;, &quot;treatment_type&quot;: &quot;Non covid vaccine&quot;, &quot;pharmacological_treatment&quot;: &quot;Non covid vaccine&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="296097" class="table-">
                
                <td>March 17, 2022, 5 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 285, &quot;treatment_name&quot;: &quot;Cigb 2020&quot;, &quot;treatment_type&quot;: &quot;Non covid vaccine&quot;, &quot;pharmacological_treatment&quot;: &quot;Non covid vaccine&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="295881" class="table-">
                
                <td>March 11, 2022, 3:30 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;CIGB 2020 vaccine;Administration; Intranasal ;Administration; Sublingual;Immunotherapy; Active;- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;Multiple doses&quot;, &quot;treatment_id&quot;: 285, &quot;treatment_name&quot;: &quot;Cigb 2020&quot;, &quot;treatment_type&quot;: &quot;Non covid vaccine&quot;, &quot;pharmacological_treatment&quot;: &quot;Non covid vaccine&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="251739" class="table-">
                
                <td>May 27, 2021, 12:45 a.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="223679" class="table-">
                
                <td>Oct. 26, 2020, 8:29 a.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;- Control Group: Conventional treatment Basic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection.   - Experimental Group: Conventional treatment + CIGB 2020 vaccine Basic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;CIGB 2020 vaccine&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Control Group: Conventional treatment Basic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection.   -&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Experimental Group: Conventional treatment + CIGB 2020 vaccine Basic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;CIGB 2020 vaccine&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

                </td>
            </tr>
            
        </tbody>
    </table>
</div>
Created at	Source	Raw Value	Validated value
July 7, 2022, 1:30 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine;- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "", "treatment_id": 285, "treatment_name": "Cigb 2020", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
June 23, 2022, 2 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "", "treatment_id": 285, "treatment_name": "Cigb 2020", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}, {"arm_notes": "no third arm. to delete", "treatment_id": 285, "treatment_name": "Cigb 2020", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
June 17, 2022, 12:30 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "CIGB 2020 vaccine;Administration; Intranasal ;Administration; Sublingual;Immunotherapy; Active;- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "", "treatment_id": 285, "treatment_name": "Cigb 2020", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
March 17, 2022, 5 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "", "treatment_id": 285, "treatment_name": "Cigb 2020", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
March 11, 2022, 3:30 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "CIGB 2020 vaccine;Administration; Intranasal ;Administration; Sublingual;Immunotherapy; Active;- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "Multiple doses", "treatment_id": 285, "treatment_name": "Cigb 2020", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
May 27, 2021, 12:45 a.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "- Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Group: Conventional treatmentBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group: Conventional treatment + CIGB 2020 vaccineBasic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;Administration; Sublingual;Administration; Intranasal ;CIGB 2020 vaccine", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]
Oct. 26, 2020, 8:29 a.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "- Control Group: Conventional treatment Basic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. - Experimental Group: Conventional treatment + CIGB 2020 vaccine Basic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;CIGB 2020 vaccine", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Group: Conventional treatment Basic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. -", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group: Conventional treatment + CIGB 2020 vaccine Basic (conventional) treatment planned in the hospital for the management of contacts and suspects of SARS-CoV-2 infection. In addition; patients will receive treatment with the CIGB 2020 vaccine nasal (scheme 0-7-14 days) and sublingually (one daily dose for 14 days).;Immunotherapy; Active;CIGB 2020 vaccine", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]